Evidence map›Paper›PMID 38314352›Full record

ArticleFrontiers in bioengineering and biotechnology2024

Christopher T Tsui, Soroush Mirkiani, David A Roszko, Matthew A Churchward, Vivian K Mushahwar, Kathryn G Todd

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in bioengineering and biotechnology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.3field-weighted citation impact, top 50% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Christopher T TsuiDepartment of Biomedical Engineering, University of Alberta, Edmonton, AB, Canada.
Soroush MirkianiNeuroscience and Mental Health Institute (NMHI), University of Alberta, Edmonton, AB, Canada.
David A RoszkoNeuroscience and Mental Health Institute (NMHI), University of Alberta, Edmonton, AB, Canada.
Matthew A ChurchwardNeurochemical Research Unit, Department of Psychiatry, University of Alberta, Edmonton, AB, Canada.
Vivian K MushahwarNeuroscience and Mental Health Institute (NMHI), University of Alberta, Edmonton, AB, Canada.
Kathryn G ToddDepartment of Biomedical Engineering, University of Alberta, Edmonton, AB, Canada.
Women and Children’s Health Research Institute · CAUniversity of Alberta · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neural interfacing devices interact with the central nervous system to alleviate functional deficits arising from disease or injury. This often entails the use of invasive microelectrode implants that elicit inflammatory responses from glial cells and leads to loss of device function. Previous work focused on improving implant biocompatibility by modifying electrode composition; here, we investigated the direct effects of electrical stimulation on glial cells at the electrode interface. A high-throughput

Indexed as

astrocytebiocompatibilityelectrical stimulationmicroelectrodemicroglianeuroinflammation

Identifiers

PMID38314352
PMCPMC10834782
OpenAlexW4391033452

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.